POPULATION PHARMACOKINETICS OF NIVOLUMAB IN JAPANESE PATIENTS WITH NON-SMALL CELL LUNG CANCER.

被引：0
|
作者：
Tohi, M. [1 ]
Mizuno, T. [2 ,3 ]
Irie, K. [1 ,4 ]
Okuyoshi, H. [1 ]
Hirabatake, M. [1 ]
Ikesue, H. [1 ]
Muroi, N. [1 ]
Eto, M. [1 ]
Tomii, K. [1 ]
Hashida, T. [1 ]
Fukushima, S. [4 ]
机构：
[1] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[3] Univ Cincinnati Coll, Cincinnati, OH USA
[4] Kobe Gakuin Univ, Kobe, Hyogo, Japan
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-069
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [31] Circadian function in patients with advanced non-small cell lung cancer.
    Levin, Robert D.
    Lis, Christopher G.
    Peterson, Caryn
    Grutsch, James F.
    Hrushesky, William Jm
    Quiton, Jovelyn
    Quinn, Kathleen
    Daehler, Maryann
    Gupta, Digant
    CANCER RESEARCH, 2006, 66 (08)
  • [32] Cachexia Index utilization in patients with non-small cell lung cancer.
    Rybar, Douglas William
    Ng, Ronald
    Fidler, Mary J.
    Kerns, Samantha
    Sayidine, Selina
    Basu, Sanjib
    Borgia, Jeffrey Allen
    Dudek, Arkadiusz Z.
    Bonomi, Philip
    Shah, Palmi
    Menchaca, Martha
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [33] Outcome of elderly patients with advanced non-small cell lung cancer.
    Gumus, M
    Palak, B
    Iyikesici, S
    Yumuk, PF
    Seker, M
    Topal, A
    Dane, F
    Salepci, T
    Yayla, A
    Turhal, NS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 706S - 706S
  • [34] Circadian function in patients with advanced non-small cell lung cancer.
    Daehier, Mary
    Levin, Robert
    Grutsch, James
    Jardinico, Joy
    Hrushesky, William
    ONCOLOGY NURSING FORUM, 2007, 34 (01) : 213 - 214
  • [35] Germline mutations among patients with non-small cell lung cancer.
    Yang, Tongtong
    Liu, Huanhuan
    Li, Mingwei
    Zhang, Yanrui
    Zhang, Yun
    Liang, Xiayuan
    Lou, Feng
    Cao, Shanbo
    Wang, Huina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Nivolumab- Induced Acute Lung Injury in Non-Small Cell Lung Cancer Patients
    Hirai, Kyoji
    Takeuchi, Shingo
    Hino, Mitsunori
    Usuda, Jitsuo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1454 - S1454
  • [37] Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer
    Chan, Phyllis
    Liu, Stephanie N.
    Gosselin, Nathalie
    Sauve, Zacharie
    Marchand, Mathilde
    Lin, Alyse
    Herraez-Baranda, Luis
    Zanghi, James
    Shearer-Kang, Esther
    Liu, Xiaoyan
    Wu, Benjamin
    Chanu, Pascal
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025,
  • [38] Influenza and mortality for non-small cell lung cancer.
    Kinslow, Connor J.
    Wang, Yuankun
    Liu, Yi
    Zuev, Konstantin M.
    Wang, Tony J. C.
    Donalek, Ciro M.
    Amori, Michael
    Cheng, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Locally advanced non-small cell lung cancer.
    Cohen E.E.
    Vokes E.E.
    Current Treatment Options in Oncology, 2001, 2 (1) : 27 - 42
  • [40] Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
    Tanaka, Kentaro
    Chamoto, Kenji
    Saeki, Sho
    Hatae, Ryusuke
    Ikematsu, Yuki
    Sakai, Kazuko
    Ando, Nobuhisa
    Sonomura, Kazuhiro
    Kojima, Shinsuke
    Taketsuna, Masanori
    Kim, Young Hak
    Yoshida, Hironori
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Hirano, Tomoko
    Matsuda, Fumihiko
    Hirai, Toyohiro
    Nishio, Kazuto
    Sakagami, Takuro
    Fukushima, Masanori
    Nakanishi, Yoichi
    Honjo, Tasuku
    Okamoto, Isamu
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (675)
12345